Why the study?
Does the endoscopic duodenal-jejunal bypass liner (DJBL) improve weight loss and cardiometabolic risk factors in morbidly obese subjects?
Population
42 morbidly obese subjects, age 36 ± 10 years, 80% female, weight 109 ± 18 kg, BMI 43.7 ± 5.9 kg/m2.
Design
Cohort, open label
Follow-up
52 weeks
Authors
Loading...
DJBL-associated weight loss in this cohort supports further study of endoscopic bariatric devices; should not yet alter practice without randomized trials.
Does the endoscopic duodenal-jejunal bypass liner (DJBL) improve weight loss and cardiometabolic risk factors in morbidly obese subjects?
The duodenal-jejunal bypass liner implanted for 1 year results in significant weight loss and improvements in cardiometabolic risk factors in morbidly obese subjects.
Escalona et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: